5 ms·
While there’s a patent issue, this is an issue of attribution (i.e. ego). I know most would prefer either a non-profit (The Broad Institute of MIT and Harvard)
by Q6T46nT668w6i3m 11y ago
While there’s a patent issue, this is an issue of attribution (i.e. ego). I know most would prefer either a non-profit (The Broad Institute of MIT and Harvard) or a public institution (University of California, Berkley) than some commercial entity.
- michaelhoffman 11y agoThe Broad Institute has given an exclusive license to a commercial entity (Editas Medicine) for certain uses of CRISPR. I don't imagine UC would behave any differently.